Journal Article Summary
The article discusses somatic symptom disorder (SSD), a condition recently classified in the DSM-5, which is the standard manual for diagnosing mental health disorders. SSD is characterized by an intense focus on physical symptoms that may not have a clear medical explanation. This topic is important because individuals with SSD often undergo unnecessary medical tests and treatments, which can lead to increased healthcare costs and negatively impact their quality of life. Understanding SSD is crucial for healthcare providers to ensure proper diagnosis and management, ultimately improving patient outcomes.
The authors present a clinical case of an elderly man who frequently visited hospitals and was diagnosed with SSD. They describe the challenges in diagnosing this disorder and highlight the need for careful management in both hospital and outpatient settings. The findings indicate that patients with SSD often experience significant distress and may require a tailored approach to their care, which can help reduce unnecessary healthcare utilization and improve their overall well-being.
Despite the insights provided, the article acknowledges limitations, such as the focus on a single case, which may not represent the broader population of individuals with SSD. It emphasizes the importance of patient safety and the need for healthcare professionals to engage in open discussions with patients about their symptoms and treatment options. Readers are encouraged to consult with their healthcare providers if they have concerns about physical symptoms that may not have a clear medical cause, as proper evaluation and management are essential for their health and quality of life.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Rosic Tea, Kalra Sameer, Samaan Zainab. Somatic symptom disorder, a new DSM-5 diagnosis of an old clinical challenge. BMJ Case Reports 2016. DOI: 10.1136/bcr-2015-212553. PMID: 26759438. PMCID: PMC4716311.
Featured Pill Pals Product
Docusate Sodium /Senna 8.6-50 mg Tablets 100 Count --- Generic for Peri-Colace --- Rugby Pharma --- Over The Counter
Docusate Sodium /Senna 8.6-50 mg Tablets 100 Count — Generic for Peri-Colace — Rugby Pharma — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
